Labshake search
Citations for R&D Systems :
1 - 50 of 1669 citations for RGPD1 2 3 4 5 8 Blocking Peptide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2021Quote: Cells were grown to 70% confluent in 24-well plates prior to treatment with N-[2-[[3-(4-Bromophenyl)-2-propenyl]amino]ethyl]-5-isoquinolinesulfonamide dihydrochloride (H89; R&D Systems) or 3-(1,3-Benzodioxol-5-ylmethylene)-2-oxo-1-pyrrolidinecarboxaldehyde (KNK437 ...
-
bioRxiv - Immunology 2021Quote: ... Blocking of ACE2 was performed with 8 ug/mL anti-ACE2 (R&D systems) for 30 min at 37°C before adding stimuli ...
-
bioRxiv - Developmental Biology 2019Quote: ... supplemented with 8 μM CHIR99021 and 4-8 ng/ml Noggin (R&D systems) for 2 days ...
-
bioRxiv - Cell Biology 2022Quote: ... αCCR7 blocking antibody (R&D systems, 2-5μg/ml), rat immunoglobulin (Ig ...
-
bioRxiv - Bioengineering 2023Quote: ... 8 μM GSK-3 inhibitor CHIR99021 (R&D Systems), 200 ng/ml fibroblast growth factor 9 (FGF9 ...
-
bioRxiv - Neuroscience 2021Quote: ... PlGF-2 (3 – 30 ng; 5 µl; cat.465-PL/CF, R&D System, USA), VEGF-E (3 – 30 ng ...
-
bioRxiv - Microbiology 2023Quote: ... separated and blotted onto 0.2 μm nitrocellulose as above and incubated overnight at 4°C in blocking buffer supplemented with 2 μg/ml polyclonal sheep IgG anti-LL-37 (R&D Systems). Membranes were washed in wash buffer (PBS with 0.05% Tween ...
-
bioRxiv - Neuroscience 2024Quote: ... Cells were passaged by dissociation in 0.5 mM EDTA every 3-4 days and resuspended in Essential 8 Medium supplemented with Y-27632 dihydrochloride (10 μM; Cat.#1254; R&D Systems). For CRISPR-Cas9 editing ...
-
bioRxiv - Immunology 2020Quote: ... the media were refreshed and supplemented with 5 ng/mL IL-7 or 5 ng/mL IL-7 and 4 ng/ml IL-2 (R&D Systems), respectively ...
-
bioRxiv - Neuroscience 2023Quote: ... for 5 min each time and subsequently incubated with blocking buffer (5% goat serum [R&D Systems, Minneapolis ...
-
bioRxiv - Immunology 2022Quote: ... or function-blocking NKG2D (5 µg/ml, R&D Systems, MAB139-100) antibodies ...
-
bioRxiv - Neuroscience 2023Quote: cleaved caspase 3 (Cat. No. MAB835, 1:200 in blocking solution, R&D Systems), dsDNA (Cat No ...
-
bioRxiv - Immunology 2020Quote: ... For iTreg cell differentiation we additionally added the following cytokines and blocking antibodies: rmIL-2 and rmTGF-β (both: R&D Systems, 5 ng/ml), anti-IL-4 (clone ...
-
bioRxiv - Cell Biology 2022Quote: ... and Laminin (R&D Systems #3446-005-01, 4-8 µg/cm2) coated glass-bottom Petri dishes (Greiner Bio-One #627975 ...
-
bioRxiv - Immunology 2022Quote: ... 5 ng/ml IL-4 (R&D Systems) and 12 ng/ml IL-10 (R&D Systems ...
-
bioRxiv - Immunology 2019Quote: ... sections were incubated overnight at 4°C with an antibody mix containing rat anti-mouse IL-18 (5 μg/ml; D047-3; R&D Systems, MN, USA) and rabbit anti-EpCAM (Clone ab71916 ...
-
bioRxiv - Molecular Biology 2023Quote: ... mouse IL-4 (5 ng/μl; R&D Systems) and TGFβ1 (2.5ng/μl ...
-
bioRxiv - Cell Biology 2021Quote: ... 5 ng/mL recombinant murine IL-3 (R&D Systems, and 5% stem cell factor-containing supernatant from CHO-KL cells for 4-6 weeks until maturation ...
-
bioRxiv - Immunology 2020Quote: ... 3 and 4 were measured using Luminex technology (R&D Systems), according to the manufacturer’s protocols ...
-
bioRxiv - Microbiology 2021Quote: ... ULBP-2/5/6 (65903, R&D systems), Plexin-B1 (rea728 ...
-
bioRxiv - Molecular Biology 2023Quote: ... 5 ng/ml FGF-2 (R&D Systems) and 1 μM CHIR99021 (STEMCELL Technologies) ...
-
bioRxiv - Neuroscience 2022Quote: ... The cells were cultured for 96 hours with MOG35-55 peptide (50 μg/mL) and Th17-polarizing factors as follows: recombinant murine (rm)IL-23 (8 ng/ml; R&D Systems), rmIL-1α (10 ng/ml ...
-
bioRxiv - Immunology 2021Quote: ... fifty microliters of stimulant pepmixes (JPT peptides) resuspended in RPMI+10%FBS (R10) with recombinant mouse IL-2 (rmIL-2) (R&D Systems) were added to each well ...
-
bioRxiv - Immunology 2022Quote: IL-4 complexes were generated by incubating 2 μg mouse rIL-4 (R&D Systems) with 10 μg LEAF purified anti-mouse IL4 antibody (clone 11B11 ...
-
bioRxiv - Cancer Biology 2020Quote: ... 5 ng/ml recombinant murine IL-4 (R&D Systems), and 5 ng/ml recombinant human TGF-β (R&D Systems) ...
-
bioRxiv - Cell Biology 2021Quote: ... and the respective growth factors and small molecules (8 µM GSK-3 inhibitor CHIR99021 (R&D Systems), 200 ng/mL FGF9 (fibroblast growth factor 9 ...
-
bioRxiv - Immunology 2019Quote: ... (5) IL-1β (2 ng/ml, R&D Systems), (6 ...
-
bioRxiv - Bioengineering 2022Quote: ... and 5 ng/mL FGF-2 (R&D systems) (MSC expansion media).
-
bioRxiv - Bioengineering 2022Quote: ... Supernatant was collected and cytokines were quantified using mouse cytokine & chemokine convenience 6-Plex kit (IL-2, IL-4, IL-5, IL-10, IFN-γ and TNF-α; # LXSAMSM-06, R&D systems) using Luminex xMAP according to manufacturers protocols.
-
bioRxiv - Cancer Biology 2023Quote: The blots were probed overnight at 4°C with monoclonal mouse anti-β-Catenin (2 µg/mL in Bovine Serum Albumin 3%, R&D Systems, Minneapolis, USA, #MAB1329), monoclonal rabbit anti-NDRG4 (1:1000 ...
-
bioRxiv - Immunology 2021Quote: ... After washing wells were incubated with a 5-bromo-4-chloro-3⍰-indolyl phosphate (BCIP)/nitro blue tetrazolium (NBT) substrate (R&D systems, mouse IFNγ Kit Cat # EL485). Plates were scanned and analyzed using ImmunoSpot Microanalyzer.
-
bioRxiv - Cancer Biology 2021Quote: ... 3 µg/mL anti-ULBP2/5/6 (clone 165903, R&D Systems), and 6 µg/mL anti-ULBP3 (clone 166510 ...
-
bioRxiv - Microbiology 2021Quote: ... 5 ng/mL BMP-4 (314-BP-050, R&D Systems), 50 ng/mL VEGF (293-VE-500 ...
-
bioRxiv - Molecular Biology 2023Quote: ... and growth factors: 5 ng/ml BMP-4 (R&D Systems), 9 ng/ml Activin A (R&D Systems) ...
-
bioRxiv - Cancer Biology 2022Quote: PBMC (2×106 per well) were stimulated in 24-well plates with peptide (individual/pool) plus recombinant IL-2 (R&D Systems Europe Ltd.) at a final concentration of 5μg/mL and 20IU/mL ...
-
bioRxiv - Developmental Biology 2023Quote: ... Cells were cultured for 4 days with 3 μM CHIR (R&D Systems); 3 days with 200 ng/mL FGF9 (R&D Systems) ...
-
bioRxiv - Cell Biology 2022Quote: ... cells were exposed for 2 days to human Activin A (8 ng/ml, R&D Systems) and human bone morphogenetic protein 4 (hBMP4 ...
-
bioRxiv - Immunology 2023Quote: ... 2 ng/mL of IL-2 and 3 ng/mL of TGFβ (R&D systems, 7666-MB-055)) conditions ...
-
bioRxiv - Immunology 2019Quote: ... and 5 ng/ml IL-4 (R&D Systems, #404-ML-010). After 24-72 hr the cells were resuspended by pipetting ...
-
bioRxiv - Genomics 2023Quote: ... followed by recombinant human BMP-4 (5 ng/mL; R&D Systems) and CHIR 99021 (1 nM ...
-
bioRxiv - Genomics 2021Quote: ... Polyclonal Goat Anti- Human/Mouse Oct-3/4 Antibody (R&D System, AF1759,1:20).
-
bioRxiv - Cancer Biology 2022Quote: ... Digested cells were washed three times with PBS and resuspended in 2/3 Cultrex Type 2 (R&D Systems) and 1/3 Full Ad-DF+++ medium and plated in drops which were allowed to solidify for 30 minutes at 37°C after which they were overlayed with Full Ad-DF+++ medium ...
-
bioRxiv - Immunology 2021Quote: ... mice were injected subcutaneously with IL-4 complex (IL-4c) comprised of rmIL-4 (2 μg, R&D systems) combined with anti-IL-4 antibody 10 μg ...
-
bioRxiv - Bioengineering 2023Quote: ... MVN and tumoroid treatments were administered over 4 days through daily media perfusion with an IL8 blocking antibody (20 µg mL-1, #MAB208, R&D Systems), Dexamethasone (5 µM ...
-
bioRxiv - Developmental Biology 2024Quote: ... Tissue was then incubated overnight at 4°C in blocking buffer with anti-E-cadherin (R&D Systems; Minneapolis, MN, USA; cat:MAB1838), anti-integrin-⍺-6 (Stem Cell Technologies ...
-
bioRxiv - Neuroscience 2021Quote: VEGF165b (3 – 30 ng; 5 µl; cat. #3045-VE-025, R&D System, USA), PlGF-2 (3 – 30 ng ...
-
bioRxiv - Microbiology 2023Quote: ... anti-IL-8/IL-8 (MAB208, R&D Systems, 1:100), anti-CD45 (2403794 ...
-
bioRxiv - Developmental Biology 2019Quote: ... in Medium B with the addition of 5 U/mL erythropoietin (EPO; Amgen) and 5 ng/mL interleukin-3 (IL3; R&D Systems). Two days later ...
-
bioRxiv - Immunology 2022Quote: ... at a final concentration of 60 pmol/peptide/mL in CTLm supplemented with 400 U/mL IL-4 and 10 ng/mL IL-7 (R&D Systems) for three days ...
-
Low-dose cytokine immunotherapy of solid cancers enabled by phagocytic-competent protein co-crystalsbioRxiv - Cancer Biology 2023Quote: ... 3 and 6 days and subsequently tested by IL-2 ELISA (R&D Systems) according to the manufacturer’s protocol.